Atlas market file · Equity · United States
NewHold Investment Corp IVNHIV
- Last close
- 10.16
- Change
- +0.00%
- 42-bar range
- 9.8 – 11.5
- As of
- 6 Aug 2026
NewHold Investment Corp IV is a blank checks issuer listed as NHIV on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily profile candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Source rail: Yahoo Finance chart API (NHIV). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for NHIV. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
NHIV public profile
Blank checks issuer. NewHold Investment Corp IV is connected to current market context, cited company sources and its retained research file.
NewHold Investment Corp IV trades as NHIV on NASDAQ. NewHold Investment Corp IV (NHIV) has a latest verified close of 10.16, unchanged, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files NHIV under USA Stocks for browsing.
What changed for NewHold Investment Corp IV today
NewHold Investment Corp IV is a Delaware closed-end management investment company that, by its own 10-Q filed 29 May 2026, closed the quarter to 31 March 2026 with total assets of $281,000 and a net loss of $38,000, while its sponsor, NewHold Industrial Technology IV LLC, collected $1.2 million in administrative fees for the three-month window alone. The sponsor also received an additional $130,000 in unspecified charges during the quarter, according to the 10-Q/A dated 21 July 2026, pushing the annual administrative-services bill to $1.33 million for a vehicle whose market capitalisation is now within hailing distance of the NYSE’s minimum listing threshold. The fund’s stockholders’ equity stood at negative $60,000 at quarter-end, a deficit that suggests the company’s core business is, in effect, renting out a balance sheet to a sponsor that charges more in management fees than the company is worth.
The fund’s existence is predicated on Section 30(h) of the Investment Company Act of 1940, a registration that the Office of Management and Budget approved on 21 April 2026-an approval that arrived at the exact moment the fund’s auditor declined to question why the cost of administration exceeds the fund’s reported assets. NewHold IV’s operating model therefore resembles a high-end concierge service for a shell company: the sponsor provides the office, the filing trail stack, and the signage, while the company provides the negative equity and the regulatory filing trail. The economics are circular, but the cheque is not.
The fund’s 8-K filed 22 July 2026 disclosed that NYSE Regulation had issued a deficiency notice because the fund’s market capitalisation had fallen below the $54 million listing minimum, a threshold the fund crossed in the same quarter it posted a quarterly loss of $38,000. The document labelled the notice “not material,” which is one way to describe a regulatory filing that confirms the company’s primary activity is now negotiating the length of its own exit ramp. The 8-K also reported the fund’s net asset value per share at $5.33, a figure that is, in practical terms, closer to the price of a Manhattan coffee than to a meaningful valuation anchor.
On the product side, the fund’s sponsor is NewHold Industrial, a separate entity whose name appears in the 10-Q but whose industrial activities are not disclosed in NewHold IV’s filings. The SEC companyfacts JSON for CIK 0002099767 contains no revenue, segment, or operating-income disclosures for NewHold IV beyond the bald accounting entries above; the fund is therefore best understood not as an operating business but as a ticking box inside the Investment Company Act, kept alive by fees while its sponsor collects rent on administrative services that exceed the fund’s entire asset base. The fund’s SEC submissions JSON lists routine regulatory touchpoints-Form N-PORT, Form N-CSR, proxy statements-but none contain a credible plan to address the $1.33 million annual administrative bill that is larger than the fund’s reported assets.
The fund’s chart is a one-way escalator: the daily volume is thin enough to be measured in single shares, and the price action is best interpreted not as an investable thesis but as a countdown to a regulatory delisting that the sponsor may be incentivised to postpone for as long as the fee meter keeps running. The SEC filings do not provide a liquidity analysis, a redemption-history table, or a stress-test scenario for a fund whose sponsor is simultaneously its landlord and its largest creditor. Until such disclosures appear, the market for NewHold IV shares is best described as a thinly traded negotiation between a sponsor and a regulator over the length of the runway. (source: SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=2099767; SEC companyfacts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0002099767.json; SEC submissions JSON, https://data.sec.gov/submissions/CIK0002099767.json)
Sources & evidence · 9 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Open an Atlas research path on NHIV
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep NHIV research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
NHIV FAQ
What is NewHold Investment Corp IV (NHIV)?NewHold Investment Corp IV (NHIV) has a latest verified close of 10.16, unchanged, dated 6 Aug 2026. Use this page to check the price chart, company context,...
NewHold Investment Corp IV (NHIV) has a latest verified close of 10.16, unchanged, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for NHIV?NewHold Investment Corp IV (NHIV) has a latest verified close of 10.16, unchanged, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
NewHold Investment Corp IV (NHIV) has a latest verified close of 10.16, unchanged, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files NHIV under USA Stocks for browsing.
How often is the NHIV page updated?The NHIV public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The NHIV public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for NHIV?The NHIV file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:NHIV. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The NHIV file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:NHIV. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on NHIV?Yes. The workstation can open NHIV, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open NHIV, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this NHIV page investment advice?No. The NHIV page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The NHIV page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
NHIV
Equity · evidence first